Home › Companies › GILEAD SCIENCES INC. › 2024-2025

GILEAD SCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and GILEAD SCIENCES INC.’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 35Reported items
  • 1,339Asset managers
  • 20,954Fund votes
  • 2025-05-07Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore GILEAD SCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by GILEAD SCIENCES INC.

These tallies are GILEAD SCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

GILEAD SCIENCES INC. — official shareholder meeting results, meeting held 2025-05-07
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Jacqueline K. Barton, Ph.D. 1,000,339,79220,090,054949,540 --99,956,982 Majority: yes
Elect Director: Jeffrey A. Bluestone, Ph.D. 1,004,363,60816,016,385999,393 --99,956,982 Majority: yes
Elect Director: Sandra J. Horning, M.D. 990,521,48029,329,8511,528,055 --99,956,982 Majority: yes
Elect Director: Kelly A. Kramer 990,682,35429,700,216996,816 --99,956,982 Majority: yes
Elect Director: Ted W. Love, M.D. 1,004,482,72315,913,306983,357 --99,956,982 Majority: yes
Elect Director: Harish Manwani 981,452,33438,691,4741,235,578 --99,956,982 Majority: yes
Elect Director: Daniel P. O'Day 953,619,78263,040,7284,718,876 --99,956,982 Majority: yes
Elect Director: Javier J. Rodriguez 1,004,096,17016,320,922962,294 --99,956,982 Majority: yes
Elect Director: Anthony Welters 986,829,94532,992,7621,556,679 --99,956,982 Majority: yes
Proposal 10 1,041,388,46878,979,344968,556 ---- Majority: yes
The Company's stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers as presented in the Proxy Statement. The proposal received the following votes: 929,612,73989,351,5012,415,146 --99,956,982 Majority: yes
Proposal 12 81,515,333935,564,3364,299,717 --99,956,982 Majority: no
The Company's stockholders did not approve a stockholder proposal requesting an independent Board Chair policy. The proposal received the following votes: 370,171,536649,612,2201,595,630 --99,956,982 Majority: no
The Company's stockholders did not approve a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process. The proposal received the following votes: 366,777,151620,731,09633,871,139 --99,956,982 Majority: no
The Company's stockholders did not approve a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors. The proposal received the following votes: 10,110,5551,007,018,0344,250,797 --99,956,982 Majority: no

Source: GILEAD SCIENCES INC., Form 8-K — read the filing on EDGAR.

How asset managers voted at the GILEAD SCIENCES INC. 2024-2025 meeting

Each item below shows how the 1,339 asset managers that disclosed a GILEAD SCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of GILEAD SCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 29 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 929,612,739AGAINST: 89,351,501

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers as presented in the Proxy Statement. The proposal received the following votes:”): 929,612,739 for, 89,351,501 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 75% for, 7% against (82% of the company cast a for/against vote).

The 1,286 asset managers below cast 95% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 94%
FOR: 94.4%AGAINST: 5.5%ABSTAIN: 0.1%NOT VOTED: 0.0%UNKNOWN: 0.0%0: 0.0%WITHHOLD/ABSTAIN: 0.0%
Largest asset managers voting on “To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy S” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Capital Group158,237,2850 00For
Vanguard137,702,72052 10For
Fidelity117,596,4590 00For
BlackRock94,582,3433,667 00For
Dodge & Cox57,745,6620 00For
Capital Research Global Investors55,619,1830 00For
State Street52,841,165483,478 00For
GEODE CAPITAL MANAGEMENT, LLC28,289,2490 00For
Wellington26,505,4260 00For
T. Rowe Price19,783,4895,775 00For
Charles Schwab16,188,0070 00For
Invesco12,641,2160 00For
Northern Trust12,219,86468,344 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional10,136,9270 00For
JPMorgan9,860,9020 00For
Victory Capital8,097,6710 00For
Federated Hermes7,814,6180 00For
MELLON INVESTMENTS Corp6,855,3020 00For
AllianceBernstein6,436,3470 00For
Pacer Funds Trust6,430,2680 00For
Legal & General Investment Management Ltd135,4216,192,510 00Against
UBS6,196,323128,752 00For
Hartford5,949,8221,027 00For
Nuveen5,609,4930 00For

Showing the 25 largest of 1,286 asset managers. See all 1,286 in the interactive database.

2. To vote on a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive compensation programs, if properly presented at the Annual Meeting.

COMPENSATION

Meeting held 2025-05-07.

Combines 10 wordings of this item as funds reported it.

0.3% fund support · no official result

AGAINST 99.4%

The 244 asset managers below cast 0.3% of the shares they voted on this item FOR (1,507,144 for, 501,612,298 against).

FOR: 1,507,144 (0.3%)AGAINST: 501,612,298 (99.5%)ABSTAIN: 1,238,336 (0.2%)NOT VOTED: 4,973 (0.0%)UNKNOWN: 400 (0.0%)NO VOTE: 53 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To vote on a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive c” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard17,174129,492,161 20Against
Capital Group0100,814,724 00Against
Fidelity069,142,656 00Against
BlackRock24,86646,202,026 00Against
Dodge & Cox026,242,492 00Against
State Street1,31814,393,314 00Against
INVESTMENT CO OF AMERICA011,192,427 00Against
Dimensional08,262,829 00Against
Charles Schwab07,881,689 00Against
Pacer Funds Trust06,430,268 00Against
T. Rowe Price06,151,664 00Against
Hartford05,874,610 00Against
VanEck ETF Trust04,730,589 00Against
TIAA04,654,296 00Against
Victory Capital04,640,970 00Against
Invesco04,009,270 00Against
Jackson National03,827,740 00Against
JPMorgan03,583,940 00Against
Federated Hermes03,085,355 00Against
First Trust02,974,121 00Against
WisdomTree02,899,891 00Against
American Century01,984,567 00Against
MASTER INVESTMENT PORTFOLIO01,980,140 00Against
ProShares01,977,645 00Against
BNY Mellon01,496,874 00Against

Showing the 25 largest of 244 asset managers. See all 244 in the interactive database.

3. To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 10 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 1,000,339,792AGAINST: 20,090,054

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Jacqueline K. Barton, Ph.D.”): 1,000,339,792 for, 20,090,054 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 80% for, 2% against (82% of the company cast a for/against vote).

The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (505,155,043 for, 88,439 against).

FOR 99.9%
FOR: 505,155,043 (99.9%)AGAINST: 88,439 (0.0%)ABSTAIN: 182,698 (0.0%)UNKNOWN: 5,305 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,32512 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

4. To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 12 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 1,004,363,608AGAINST: 16,016,385

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Jeffrey A. Bluestone, Ph.D.”): 1,004,363,608 for, 16,016,385 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 81% for, 1% against (82% of the company cast a for/against vote).

The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (505,182,012 for, 61,465 against).

FOR 99.9%
FOR: 505,182,012 (100.0%)AGAINST: 61,465 (0.0%)ABSTAIN: 182,701 (0.0%)UNKNOWN: 5,305 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,32710 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

5. To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 11 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 990,521,480AGAINST: 29,329,851

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Sandra J. Horning, M.D.”): 990,521,480 for, 29,329,851 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 80% for, 2% against (82% of the company cast a for/against vote).

The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (505,106,147 for, 137,293 against).

FOR 99.9%
FOR: 505,106,147 (99.9%)AGAINST: 137,293 (0.0%)ABSTAIN: 182,739 (0.0%)UNKNOWN: 5,305 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,32116 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

6. To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 10 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 990,682,354AGAINST: 29,700,216

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Kelly A. Kramer”): 990,682,354 for, 29,700,216 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 80% for, 2% against (82% of the company cast a for/against vote).

The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (505,027,242 for, 216,235 against).

FOR 99.9%
FOR: 505,027,242 (99.9%)AGAINST: 216,235 (0.0%)ABSTAIN: 182,701 (0.0%)UNKNOWN: 5,305 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,492,19417,143 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

7. To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 12 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 1,004,482,723AGAINST: 15,913,306

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Ted W. Love, M.D.”): 1,004,482,723 for, 15,913,306 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 81% for, 1% against (82% of the company cast a for/against vote).

The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (505,146,308 for, 65,207 against).

FOR 99.9%
FOR: 505,146,308 (99.9%)AGAINST: 65,207 (0.0%)ABSTAIN: 214,664 (0.0%)UNKNOWN: 5,305 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,32710 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

8. To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish Manwani

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 10 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 981,452,334AGAINST: 38,691,474

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Harish Manwani”): 981,452,334 for, 38,691,474 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 79% for, 3% against (82% of the company cast a for/against vote).

The 217 asset managers below cast 99.6% of the shares they voted on this item FOR (503,629,507 for, 1,613,954 against).

FOR 99.6%
FOR: 503,629,507 (99.6%)AGAINST: 1,613,954 (0.3%)ABSTAIN: 182,718 (0.0%)UNKNOWN: 5,305 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,31423 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

9. To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 11 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 953,619,782AGAINST: 63,040,728

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Daniel P. O'Day”): 953,619,782 for, 63,040,728 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 77% for, 5% against (82% of the company cast a for/against vote).

The 217 asset managers below cast 99.8% of the shares they voted on this item FOR (504,695,217 for, 547,995 against).

FOR 99.8%
FOR: 504,695,217 (99.9%)AGAINST: 547,995 (0.1%)ABSTAIN: 182,967 (0.0%)UNKNOWN: 5,305 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,29738 30For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,54092 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

10. To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 9 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 1,004,096,170AGAINST: 16,320,922

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Javier J. Rodriguez”): 1,004,096,170 for, 16,320,922 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 81% for, 1% against (82% of the company cast a for/against vote).

The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (505,156,762 for, 86,719 against).

FOR 99.9%
FOR: 505,156,762 (99.9%)AGAINST: 86,719 (0.0%)ABSTAIN: 182,699 (0.0%)UNKNOWN: 5,305 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,32710 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

11. To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 9 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 986,829,945AGAINST: 32,992,762

GILEAD SCIENCES INC.’s own tally for this item (“Elect Director: Anthony Welters”): 986,829,945 for, 32,992,762 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 79% for, 3% against (82% of the company cast a for/against vote).

The 217 asset managers below cast 99.9% of the shares they voted on this item FOR (505,067,648 for, 175,789 against).

FOR 99.9%
FOR: 505,067,648 (99.9%)AGAINST: 175,789 (0.0%)ABSTAIN: 182,741 (0.0%)UNKNOWN: 5,305 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until th” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,509,31720 10For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,6320 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,827,7400 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon1,496,8740 00For

Showing the 25 largest of 217 asset managers. See all 217 in the interactive database.

12. To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATED

Meeting held 2025-05-07.

Combines 5 wordings of this item as funds reported it.

99.5% fund support · no official result

FOR 99.5%

The 209 asset managers below cast 99.5% of the shares they voted on this item FOR (501,875,071 for, 2,142,275 against).

FOR: 501,875,071 (99.5%)AGAINST: 2,142,275 (0.4%)ABSTAIN: 182,677 (0.0%)UNKNOWN: 400 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fisc” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard129,492,16517,173 00For
Capital Group100,814,7240 00For
Fidelity69,142,6560 00For
BlackRock46,226,8920 00For
Dodge & Cox26,242,4920 00For
State Street14,394,400232 00For
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional8,262,8290 00For
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price6,151,6640 00For
Hartford5,873,5831,027 00For
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital4,640,9700 00For
Invesco4,009,2700 00For
Jackson National3,431,134396,606 00For
JPMorgan3,583,9400 00For
Federated Hermes3,085,3550 00For
First Trust2,974,1210 00For
WisdomTree2,899,8910 00For
American Century1,984,5670 00For
MASTER INVESTMENT PORTFOLIO1,980,1400 00For
ProShares1,977,6450 00For
BNY Mellon265,1531,231,721 00Against

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

13. To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.

CORPORATE GOVERNANCE

Meeting held 2025-05-07.

Combines 5 wordings of this item as funds reported it.

31% fund support · no official result

FOR 31%AGAINST 69%

The 209 asset managers below cast 31% of the shares they voted on this item FOR (158,365,185 for, 345,652,500 against).

FOR: 158,365,185 (31.4%)AGAINST: 345,652,500 (68.6%)ABSTAIN: 182,739 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the A” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard17,130,092112,379,245 10Against
Capital Group100,814,7240 00For
Fidelity761,29768,381,359 00Against
BlackRock40,15346,186,739 00Against
Dodge & Cox026,242,492 00Against
State Street2,81114,391,821 00Against
INVESTMENT CO OF AMERICA11,192,4270 00For
Dimensional08,262,829 00Against
Charles Schwab07,881,689 00Against
Pacer Funds Trust06,430,268 00Against
T. Rowe Price06,151,664 00Against
Hartford5,874,6100 00For
VanEck ETF Trust4,730,5890 00For
TIAA04,654,296 00Against
Victory Capital1,2874,639,683 00Against
Invesco04,009,270 00Against
Jackson National3,175,769651,971 00For
JPMorgan03,583,940 00Against
Federated Hermes3,085,3550 00For
First Trust02,974,121 00Against
WisdomTree2,899,8910 00For
American Century01,984,567 00Against
MASTER INVESTMENT PORTFOLIO01,980,140 00Against
ProShares01,977,645 00Against
BNY Mellon265,1531,231,721 00Against

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

14. To vote on a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process, if properly presented at the Annual Meeting.

HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE

Meeting held 2025-05-07.

Combines 4 wordings of this item as funds reported it.

11% fund support · no official result

10%AGAINST 84%

The 209 asset managers below cast 11% of the shares they voted on this item FOR (52,311,970 for, 425,982,548 against).

FOR: 52,311,970 (10.4%)AGAINST: 425,982,548 (84.5%)ABSTAIN: 25,905,906 (5.1%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To vote on a stockholder proposal requesting a comprehensive human rights policy and human rights due diligenc” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard310,073129,199,244 210Against
Capital Group0100,814,724 00Against
Fidelity839,53043,334,046 24,969,0800Against
BlackRock40,15346,186,739 00Against
Dodge & Cox026,242,492 00Against
State Street3,77714,390,855 00Against
INVESTMENT CO OF AMERICA011,192,427 00Against
Dimensional300,5177,962,312 00Against
Charles Schwab7,881,6890 00For
Pacer Funds Trust6,430,2680 00For
T. Rowe Price06,151,664 00Against
Hartford1,0275,873,583 00Against
VanEck ETF Trust4,730,5890 00For
TIAA4,654,2960 00For
Victory Capital04,640,970 00Against
Invesco1,1494,008,121 00Against
Jackson National396,6063,431,134 00Against
JPMorgan2783,583,662 00Against
Federated Hermes3,085,3550 00For
First Trust02,974,121 00Against
WisdomTree02,899,891 00Against
American Century01,984,567 00Against
MASTER INVESTMENT PORTFOLIO01,980,140 00Against
ProShares1,977,6450 00For
BNY Mellon1,231,721265,153 00For

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

15. To vote on a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors, if properly presented at the Annual Meeting.

DIVERSITY, EQUITY, AND INCLUSION

Meeting held 2025-05-07.

Combines 5 wordings of this item as funds reported it.

0.1% fund support · no official result

AGAINST 99.7%

The 209 asset managers below cast 0.1% of the shares they voted on this item FOR (226,574 for, 503,033,758 against).

FOR: 226,574 (0.0%)AGAINST: 503,033,758 (99.8%)ABSTAIN: 934,787 (0.2%)UNKNOWN: 5,305 (0.0%)WITHHOLD/ABSTAIN: 13 (0.0%)
Largest asset managers voting on “To vote on a stockholder proposal requesting a report on the risks of the Company's DEI practices for contract” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6129,509,329 30Against
Capital Group0100,814,724 00Against
Fidelity069,142,656 00Against
BlackRock046,226,892 00Against
Dodge & Cox026,242,492 00Against
State Street014,394,632 00Against
INVESTMENT CO OF AMERICA011,192,427 00Against
Dimensional08,262,829 00Against
Charles Schwab07,881,689 00Against
Pacer Funds Trust06,430,268 00Against
T. Rowe Price06,151,664 00Against
Hartford05,874,610 00Against
VanEck ETF Trust04,730,589 00Against
TIAA04,654,296 00Against
Victory Capital04,640,970 00Against
Invesco04,009,270 00Against
Jackson National03,827,740 00Against
JPMorgan03,583,940 00Against
Federated Hermes03,085,355 00Against
First Trust02,974,121 00Against
WisdomTree02,899,891 00Against
American Century01,984,567 00Against
MASTER INVESTMENT PORTFOLIO01,980,140 00Against
ProShares01,977,645 00Against
BNY Mellon01,496,874 00Against

Showing the 25 largest of 209 asset managers. See all 209 in the interactive database.

16. Section 14a Executive Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-07.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 929,612,739AGAINST: 89,351,501

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers as presented in the Proxy Statement. The proposal received the following votes:”): 929,612,739 for, 89,351,501 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 75% for, 7% against (82% of the company cast a for/against vote).

The 22 asset managers below cast 91% of the shares they voted on this item FOR (109,285 for, 10,611 against).

FOR 88%9%
FOR: 109,285 (88.4%)AGAINST: 10,611 (8.6%)NOT VOTED: 3,755 (3.0%)
Largest asset managers voting on “Section 14a Executive Compensation” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Simplify Exchange Traded Funds62,2150 00For
Focus Partners Wealth19,3868,408 00For
PEDDOCK CAPITAL ADVISORS, LLC20,6990 00For
LEAVELL INVESTMENT MANAGEMENT, INC.00 00Not Voted
COURIER CAPITAL LLC1,8370 00For
HARBOUR INVESTMENT MANAGEMENT LLC1,0100 00For
Blue Edge Capital, LLC1,0000 00For
Vancity Investment Management Ltd0884 00Against
Campion Asset Management0750 00Against
BOURNE LENT ASSET MANAGEMENT INC6800 00For
Ballew Advisors, Inc304301 00For
Baker Avenue Asset Management, LP4300 00For
MQS Management LLC4200 00For
Blue Fin Capital, Inc.4000 00For
IMA Advisory Services, Inc.3490 00For
OLD SECOND NATIONAL BANK OF AURORA3000 00For
WOODARD & CO ASSET MANAGEMENT GROUP INC /ADV0268 00Against
Wallington Asset Management, LLC1070 00For
WESPAC Advisors SoCal, LLC1000 00For
Claret Asset Management Corp300 00For
VOISARD ASSET MANAGEMENT GROUP, INC.180 00For
SCHOLTZ & COMPANY, LLC00 00--

17. Report on Pay Disparity

DIVERSITY, EQUITY, AND INCLUSION

Meeting held 2025-05-07.

44% fund support · no official result

FOR 44%AGAINST 56%

The 9 asset managers below cast 44% of the shares they voted on this item FOR (358,500 for, 455,080 against).

FOR: 358,500 (44.1%)AGAINST: 455,080 (55.9%)
Largest asset managers voting on “Report on Pay Disparity” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH358,5000 00For
GuideStone0219,348 00Against
Empower0175,194 00Against
Northern Lights Fund Trust027,404 00Against
CLEARWATER INVESTMENT TRUST017,117 00Against
Northern Lights Variable Trust015,728 00Against
Canopy Partners, LLC0184 00Against
CIDEL ASSET MANAGEMENT INC065 00Against
Balentine LLC040 00Against

18. To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-05-08 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 928,702,915AGAINST: 78,647,808

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers as presented in the Proxy Statement. The proposal received the following votes:”): 928,702,915 for, 78,647,808 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 75% for, 6% against (81% of the company cast a for/against vote).

The 8 asset managers below cast 45% of the shares they voted on this item FOR (16,570 for, 20,371 against).

FOR 45%AGAINST 55%
FOR: 16,570 (44.9%)AGAINST: 20,371 (55.1%)
Largest asset managers voting on “To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy S” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Knuff & Co LLC020,371 00Against
COLDSTREAM CAPITAL MANAGEMENT INC11,3020 00For
USCF ETF Trust2,1600 00For
Ipswich Investment Management Co., Inc.1,8950 00For
Americana Partners, LLC6080 00For
VAUGHAN DAVID INVESTMENTS LLC/IL4360 00For
Axiom Financial Strategies, LLC1690 00For
Echo45 Advisors LLC00 00--

19. Report on the Risks of DEI Practices for Contractors

DIVERSITY, EQUITY, AND INCLUSIONMajority of the votes cast: no

Meeting held 2025-05-07.

Combines 2 wordings of this item as funds reported it.

1.0% Majority: no · of votes cast

AGAINST 99.0%
FOR: 10,110,555AGAINST: 1,007,018,034

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders did not approve a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors. The proposal received the following votes:”): 10,110,555 for, 1,007,018,034 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 0.9% for, 81% against (82% of the company cast a for/against vote).

The 7 asset managers below cast 71% of the shares they voted on this item FOR (577,848 for, 235,747 against).

FOR 71%AGAINST 29%
FOR: 577,848 (71.0%)AGAINST: 235,747 (29.0%)
Largest asset managers voting on “Report on the Risks of DEI Practices for Contractors” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH358,5000 00For
GuideStone219,3480 00For
Empower0175,194 00Against
Northern Lights Fund Trust027,404 00Against
CLEARWATER INVESTMENT TRUST017,117 00Against
Northern Lights Variable Trust015,728 00Against
Ballew Advisors, Inc0304 00Against

20. Adopt Comprehensive Human Rights Policy and Human Rights Due Diligence Process

HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCEMajority of the votes cast: no

Meeting held 2025-05-07.

37% Majority: no · of votes cast

FOR 37%AGAINST 63%
FOR: 366,777,151AGAINST: 620,731,096

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders did not approve a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process. The proposal received the following votes:”): 366,777,151 for, 620,731,096 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 29% for, 49.9% against (79% of the company cast a for/against vote).

The 6 asset managers below cast 73% of the shares they voted on this item FOR (593,943 for, 219,348 against).

FOR 73%AGAINST 27%
FOR: 593,943 (73.0%)AGAINST: 219,348 (27.0%)
Largest asset managers voting on “Adopt Comprehensive Human Rights Policy and Human Rights Due Diligence Process” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH358,5000 00For
GuideStone0219,348 00Against
Empower175,1940 00For
Northern Lights Fund Trust27,4040 00For
CLEARWATER INVESTMENT TRUST17,1170 00For
Northern Lights Variable Trust15,7280 00For

21. Ratify Appointment of Independent Auditors

AUDIT-RELATED

Meeting held 2025-05-07.

Combines 2 wordings of this item as funds reported it.

27% fund support · no official result

FOR 27%AGAINST 73%

The 6 asset managers below cast 27% of the shares they voted on this item FOR (128,734 for, 347,432 against).

FOR: 128,734 (27.0%)AGAINST: 347,432 (73.0%)
Largest asset managers voting on “Ratify Appointment of Independent Auditors” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Cardano Risk Management B.V.0347,432 00Against
Simplify Exchange Traded Funds62,2150 00For
AMERICAN BEACON FUNDS47,7000 00For
MARCO INVESTMENT MANAGEMENT LLC17,7910 00For
HARBOUR INVESTMENT MANAGEMENT LLC1,0100 00For
VOISARD ASSET MANAGEMENT GROUP, INC.180 00For

22. Ratify Ernst & Young LLP as Auditors

AUDIT-RELATED

Meeting held 2025-05-07.

100% fund support · no official result

FOR 100%

The 6 asset managers below cast 100% of the shares they voted on this item FOR (813,291 for, 0 against).

FOR: 813,291 (100.0%)
Largest asset managers voting on “Ratify Ernst & Young LLP as Auditors” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH358,5000 00For
GuideStone219,3480 00For
Empower175,1940 00For
Northern Lights Fund Trust27,4040 00For
CLEARWATER INVESTMENT TRUST17,1170 00For
Northern Lights Variable Trust15,7280 00For

23. Require Independent Board Chair

CORPORATE GOVERNANCEMajority of the votes cast: no

Meeting held 2025-05-07.

36% Majority: no · of votes cast

FOR 36%AGAINST 64%
FOR: 370,171,536AGAINST: 649,612,220

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders did not approve a stockholder proposal requesting an independent Board Chair policy. The proposal received the following votes:”): 370,171,536 for, 649,612,220 against, per its Form 8-K (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 30% for, 52.2% against (82% of the company cast a for/against vote).

The 6 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 813,291 against).

AGAINST 100%
AGAINST: 813,291 (100.0%)
Largest asset managers voting on “Require Independent Board Chair” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Erste Asset Management GmbH0358,500 00Against
GuideStone0219,348 00Against
Empower0175,194 00Against
Northern Lights Fund Trust027,404 00Against
CLEARWATER INVESTMENT TRUST017,117 00Against
Northern Lights Variable Trust015,728 00Against

24. Shareholder Proposal Regarding Including Pay Ratio in Executive Compensation

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-05-07.

99.7% fund support · no official result

FOR 99.7%

The 6 asset managers below cast 99.7% of the shares they voted on this item FOR (509,853 for, 1,470 against).

FOR: 509,853 (99.7%)AGAINST: 1,470 (0.3%)
Largest asset managers voting on “Shareholder Proposal Regarding Including Pay Ratio in Executive Compensation” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Cardano Risk Management B.V.347,4320 00For
Union Investment Institutional GmbH61,5040 00For
AMERICAN BEACON FUNDS47,7000 00For
OSSIAM44,9070 00For
Union Investment Privatfonds GmbH8,3100 00For
ALGERT GLOBAL LLC01,470 00Against

25. S/H Proposal - Executive Compensation

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2025-05-07.

99.9% fund support · no official result

FOR 97%

The 5 asset managers below cast 99.9% of the shares they voted on this item FOR (65,970 for, 18 against).

FOR: 65,970 (97.0%)AGAINST: 18 (0.0%)ABSTAIN: 1,000 (1.5%)NOT VOTED: 1,010 (1.5%)
Largest asset managers voting on “S/H Proposal - Executive Compensation” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Simplify Exchange Traded Funds62,2150 00For
LEAVELL INVESTMENT MANAGEMENT, INC.3,7550 00For
HARBOUR INVESTMENT MANAGEMENT LLC00 00Not Voted
Blue Edge Capital, LLC00 1,0000Abstain
VOISARD ASSET MANAGEMENT GROUP, INC.018 00Against

26. S/H Proposal - Corporate Governance

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2025-05-07.

Combines 2 wordings of this item as funds reported it.

99.3% fund support · no official result

FOR 98%

The 4 asset managers below cast 99.3% of the shares they voted on this item FOR (62,215 for, 437 against).

FOR: 62,215 (97.7%)AGAINST: 437 (0.7%)NOT VOTED: 1,010 (1.6%)
Largest asset managers voting on “S/H Proposal - Corporate Governance” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Simplify Exchange Traded Funds62,2150 00For
HARBOUR INVESTMENT MANAGEMENT LLC00 00Not Voted
Members Trust Co0419 00Against
VOISARD ASSET MANAGEMENT GROUP, INC.018 00Against

27. Election of Directors (Majority Voting)

DIRECTOR ELECTIONS

Meeting held 2025-05-07.

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR.

FOR: 100.0%
Largest asset managers voting on “Election of Directors (Majority Voting)” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Simplify Exchange Traded Funds62,2150 00For
HARBOUR INVESTMENT MANAGEMENT LLC9,0900 00For
VOISARD ASSET MANAGEMENT GROUP, INC.180 00For

28. S/H Proposal - Establish Independent Chairman

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2025-05-07.

99.9% fund support · no official result

FOR 98%

The 3 asset managers below cast 99.9% of the shares they voted on this item FOR (62,215 for, 18 against).

FOR: 62,215 (98.4%)AGAINST: 18 (0.0%)NOT VOTED: 1,010 (1.6%)
Largest asset managers voting on “S/H Proposal - Establish Independent Chairman” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Simplify Exchange Traded Funds62,2150 00For
HARBOUR INVESTMENT MANAGEMENT LLC00 00Not Voted
VOISARD ASSET MANAGEMENT GROUP, INC.018 00Against

29. S/H Proposal - Human Rights Related

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2025-05-07.

100% fund support · no official result

FOR 98%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (62,233 for, 0 against).

FOR: 62,233 (98.4%)NOT VOTED: 1,010 (1.6%)
Largest asset managers voting on “S/H Proposal - Human Rights Related” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Simplify Exchange Traded Funds62,2150 00For
HARBOUR INVESTMENT MANAGEMENT LLC00 00Not Voted
VOISARD ASSET MANAGEMENT GROUP, INC.180 00For

30. COMPENSATION

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-07.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 929,612,739AGAINST: 89,351,501

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers as presented in the Proxy Statement. The proposal received the following votes:”): 929,612,739 for, 89,351,501 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 75% for, 7% against (82% of the company cast a for/against vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (1,621 for, 0 against).

FOR 100%
FOR: 1,621 (100.0%)
Largest asset managers voting on “COMPENSATION” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Capital Group1,0520 00For
Members Trust Co4190 00For
Blue Sky Capital Consultants Group, Inc.1500 00For

31. SECTION 14A SAY-ON-PAY VOTES

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-07.

Combines 2 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 929,612,739AGAINST: 89,351,501

GILEAD SCIENCES INC.’s own tally for this item (“The Company's stockholders approved, on an advisory basis, the compensation of the Company's Named Executive Officers as presented in the Proxy Statement. The proposal received the following votes:”): 929,612,739 for, 89,351,501 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,245,000,000 outstanding shares: 75% for, 7% against (82% of the company cast a for/against vote).

The 2 asset managers below cast 100% of the shares they voted on this item FOR (21,894 for, 0 against).

FOR 100%
FOR: 21,894 (100.0%)
Largest asset managers voting on “SECTION 14A SAY-ON-PAY VOTES” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Lido Advisors, LLC21,6850 00For
Pinnacle Family Advisors, LLC2090 00For

32. Director Elections

DIRECTOR ELECTIONS

Meeting held 2025-05-07.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (723 for, 0 against).

FOR: 723 (100.0%)
Largest asset managers voting on “Director Elections” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Members Trust Co4190 00For
Ballew Advisors, Inc3040 00For

33. Shareholder Proposal Regarding Human Rights Policy

HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE

Meeting held 2025-05-07.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (395,132 for, 0 against).

FOR: 395,132 (100.0%)
Largest asset managers voting on “Shareholder Proposal Regarding Human Rights Policy” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Cardano Risk Management B.V.347,4320 00For
AMERICAN BEACON FUNDS47,7000 00For

34. Shareholder Proposal Regarding Independent Chair

CORPORATE GOVERNANCE

Meeting held 2025-05-07.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (395,132 for, 0 against).

FOR: 395,132 (100.0%)
Largest asset managers voting on “Shareholder Proposal Regarding Independent Chair” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Cardano Risk Management B.V.347,4320 00For
AMERICAN BEACON FUNDS47,7000 00For

35. Shareholder Proposal Regarding Report on DEI Requirements for Contractors

OTHER SOCIAL ISSUES

Meeting held 2025-05-07.

0% fund support · no official result

AGAINST 100%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 395,132 against).

AGAINST: 395,132 (100.0%)
Largest asset managers voting on “Shareholder Proposal Regarding Report on DEI Requirements for Contractors” at GILEAD SCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Cardano Risk Management B.V.0347,432 00Against
AMERICAN BEACON FUNDS047,700 00Against

Largest GILEAD SCIENCES INC. shareholders voting in 2024-2025

Ranked by the number of GILEAD SCIENCES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 1,245,000,000 shares outstanding at the time of that meeting.

Top GILEAD SCIENCES INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Capital Group 12.71%
2Vanguard 11.06%
3Fidelity 9.45%
4BlackRock 7.60%
5Dodge & Cox 4.64%
6Capital Research Global Investors 4.47%
7State Street 4.28%
8GEODE CAPITAL MANAGEMENT, LLC 2.27%
9Wellington 2.13%
10T. Rowe Price 1.59%

Reported GILEAD SCIENCES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

GILEAD SCIENCES INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
The Vanguard Group 8.98% DEF14A
BlackRock, Inc. 8.17% 13G
State Street 4.78% 13F
FMR (Fidelity) 4.70% 13F
Capital World Investors 4.32% 13G
Wellington Management 2.20% 13F
Morgan Stanley 1.59% 13F
Norges Bank 1.39% 13F
BNY Mellon 1.28% 13F
T. Rowe Price 1.18% 13F

Percentages above are of 1,245,000,000 shares outstanding, as reported by GILEAD SCIENCES INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from GILEAD SCIENCES INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At GILEAD SCIENCES INC.'s shareholder meeting held 2025-05-07, in the 2024-2025 proxy season, 1,339 asset managers reported how they voted in their SEC Form N-PX filings, covering 20,954 separate fund positions. Their filings are grouped here into 35 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our Named Executive Officers as presented… — FOR was 91% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: GILEAD SCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

GILEAD SCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.